CIK 0000898437 · Accelerated filer
Anika Therapeutics, Inc.
Sign in to watch- Ticker
- ANIK
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043145961
- Phone
- (781) 457-9000
- Business address
- 32 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ANIKA THERAPEUTICS INC, ANIKA RESEARCH INC
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 144 Insider Sale of Securities
- 4 Open-market buy Director bought 2,000 shares at an average $20.53 ($41,060)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · New debt or obligation
- 4 Grant or award Director acquired 10,402 shares (grant or award)
- 4 Grant or award Director acquired 10,402 shares (grant or award)
- 4 Grant or award Director acquired 10,402 shares (grant or award)
- 4 Grant or award Director acquired 10,402 shares (grant or award)
- 4 Grant or award Director acquired 10,402 shares (grant or award)
- 8-K Event Executive or director change · Shareholder vote results
- DEFA14A Proxy Proxy Materials
- 4 Shares withheld for taxes President and CEO gave up 3,769 shares (to pay taxes)
- DEFA14A Proxy Proxy Materials
- 4 Open-market buy Director bought 5,000 shares at $14.66 ($73,320)
Page 1 of 55 · 1,098 filings